Status:
COMPLETED
CT Guided CI Programming
Lead Sponsor:
University of California, San Francisco
Conditions:
Cochlear Implants
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current standard of care for cochlear implants (CI) does not address the significant pitch-place mismatch that is inherent in cochlear implantation (see detailed description below). The present st...
Detailed Description
Pitch perception is a fundamental component of how humans process sound. Individuals who use cochlear implants (CIs), surgically implanted devices which are able to restore a limited range of hearing,...
Eligibility Criteria
Inclusion
- Has or plans to have a MED-EL cochlear implant (CI)
- Has not yet had their CI activated
- Be able and willing to participate in all of the research appointments for follow-up testing (e.g., 1, 3, 6, 12, and 13 months post-CI activation)
- Be willing to use the CI full-time (during waking hours) for 13 months post-activation
- Is able to speak and read American English
- Uses oral/aural communication as primary communication modality
Exclusion
- Intra-cochlear electrodes known to be open or short-circuits
- Partially-inserted CI with fewer than 10 intra-cochlear electrodes
- Any concomitant condition(s) that may affect performance on speech and music test battery (e.g., cognitive impairment)
- Atypical cochlear anatomy (e.g., fewer than 2 turns of the cochlea)
- Pregnancy (a contraindication for CT scan)
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04506424
Start Date
September 1 2021
End Date
April 8 2024
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94115